CD4 and angina pectoris: A retrospective clinical study found that unstable angina patients treated with statins for at least 1 month had fewer CD4+CD28null T cells than those given standard anti-ischemic therapy without statins, an effect that correlated well with plasma C-reactive protein (CRP) levels (14).